The effect of combination therapy of methylphenidate and Atomoxetine in the treatment of hyperactivity-disordered children

The Effect of Methylphenidate and Atomoxetine Combination Therapy in the Treatment of Children with Hyperactivity Disorder - Attention Deficit with Relative Response to Single Medicinal Therapy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190526043708N1

Enrollment

Registered

2019-12-23

Start date

2018-07-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder.

Interventions

Intervention group: Patients with attention deficit hyperactivity disorder were divided into two groups, half of them were treated with 4 weeks of atomoxetine and the other half were treated with 4 we

Eligibility

Sex/Gender

All

Age

6 Years to 17 Years

Inclusion criteria

Inclusion criteria: Patients with ADHD aged 6-17 years patients who are not treated concurrently with medicinal or non-drug therapy IQ of more than 70

Exclusion criteria

Exclusion criteria: Family dissatisfaction with continued treatment Incidence of side effects

Design outcomes

Primary

Measure	Time frame
Parents' ADHD/RS Score. Timepoint: 0 and 4 weeks later. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Pourmahmoudian

Mashhad University of Medical Sciences

pourmahmoodian.m@gmail.com+98 51 3700 2202

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026